Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Cancer Genomics & Proteomics|April 26, 2019
Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast CancerGeorgios Lazaridis, Vassiliki Kotoula, Eleni Vrettou, et al.Oncotarget|October 28, 2015
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trialsVassiliki Kotoula, Kyriakos Chatzopoulos, Sotiris Lakis, et al.Cancer Genomics & Proteomics|October 30, 2019
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for TreatmentHelena Linardou, Vassiliki Kotoula, George Kouvatseas, et al.Plos One|September 30, 2016
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesVassiliki Kotoula, Sotiris Lakis, Ioannis S Vlachos, et al.Clinical Colorectal Cancer|August 13, 2019
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and BevacizumabGeorge Pentheroudakis, Leonidas Mavroeidis, Kyriaki Papadopoulou, et al.BMC Cancer|February 5, 2013
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypesGeorge Pentheroudakis, Vassiliki Kotoula, Wendy De Roock, et al.Oncotarget|November 28, 2018
Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancerElena Fountzilas, Vassiliki Kotoula, Ioannis Tikas, et al.Anticancer Research|August 27, 2011
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluationGeorge Fountzilas, Helen P Kourea, Mattheos Bobos, et al.Plos One|August 8, 2013
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG)George Pentheroudakis, Vassiliki Kotoula, Anastasia G Eleftheraki, et al.Journal of Cancer Research and Clinical Oncology|March 6, 2014
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximabEvangelia Razis, George Pentheroudakis, George Rigakos, et al.Pageof 5